期刊文献+

mTORC1抑制剂影响谷氨酰胺代谢抑制人胰腺神经内分泌肿瘤细胞增殖 被引量:1

mTORC1 inhibitor inhibit human pancreatic neuroendocrine tumors cell proliferation by influence glutamine metabolism
下载PDF
导出
摘要 目的体外研究雷帕霉素靶蛋白复合物1(mTORC1)抑制剂对人胰腺神经内分泌肿瘤(pNET)细胞株BON增殖的影响,探讨谷氨酰胺(Gln)代谢在mTORC1抑制剂影响BON细胞增殖中的作用。方法体外培养人胰腺神经内分泌肿瘤细胞BON,分别用1、5、10、25、50、100nM的雷帕霉素处理后,应用CCK-8检测BON的生长抑制率。用100nM雷帕霉素处理BON细胞12h后,检测其对Gln的吸收水平。在无葡萄糖(Glc)和(或)无谷氨酰胺(Gln)的情况下,应用CCK-8检测BON的增殖情况以及流式细胞术检测细胞周期情况。结果雷帕霉素可明显抑制BON细胞的增殖,抑制率呈时间-浓度依赖性(P<0.05)。同时雷帕霉素影响BON对Gln的吸收,而BON明显依赖于Gln生长,Glc-/Gln+组、Glc-/Gln-组、Glc+/Gln-组生长速率较Glc+/Gln+组差异有统计学意义(P<0.05)。结论 mTORC1抑制剂可能通过影响Gln代谢抑制BON细胞的增殖。 Objective To evaluatethe effect of mTORC1 inhibitor on the proliferation in human pancreatic neuroendocrine tumors(pNET)cell line BON,to explore the function of glutamine metabolism in it.Methods In vitro cultured human pancreatic neuroendocrine tumors(pNET)cell line BON,BON cells were treated with different concentrations of rapamycin(1,5,10,25,50,100nM)for 12,24 h.Then CCK-8assay are used to calculate the growth inhibitory rate.Rapamycin treated with BON 12 h,test the glutamine uptake level compared with control.Then deprive of glucose and/or glutamine,CCK-8assay were used in observation of cell proliferation,cell cycle distribution was analyzed by flow cytomety.Results Rapamycin significantly inhibited the growth of BON cells in a time-and dose-dependent manner(P〈0.05).Meanwhile,rapamycin can reduce the glutamine uptake level compared with control.BON obviously depends on glutamine for growth,without glucose and glutamine group have obvious difference in growth rate(P〈0.05).Conclusion mTORC1 inhibitor can inhibit BON cells proliferation and influence the glutamine uptake level.suggesting that mTORC1 inhibitor might inhibit BON cells proliferation by influenced the glutamine metabolic pathway.
出处 《重庆医学》 CAS 北大核心 2015年第6期738-740,共3页 Chongqing medicine
基金 中国临床肿瘤学科学基金(Y-N2013-006)
关键词 细胞增殖 谷氨酰胺代谢 mTORC1抑制剂 胰腺神经内分泌肿瘤 cell proliferation glutamine metabolism mTORC1inhibitor pancreaticneuroendocrine tumors
  • 相关文献

参考文献15

  • 1Csibi A, Fendt SM, Li C, et al. The mTORCl pathwaystimulates glutamine metabolism and cell proliferation byrepressing SIRT4[J]. Cell,2013 ,153(4) :840-854. 被引量:1
  • 2易梅,向波,李小玲,李桂源.代谢重编程:肿瘤的平衡之舞[J].中南大学学报(医学版),2013,38(11):1177-1187. 被引量:18
  • 3Robey IF,Stephen RM,Brown KS,et al. Regulation of theWarburg effect in early-passage breast cancer cells [J].Neoplasia,2008,10(8) :745-756. 被引量:1
  • 4Ma WW, Jacene H, Song D, et al. [ 18F]fluorodeoxyglu-cose positron emission tomography correlates with Aktpathway activity but is not predictive of clinical outcomeduring mTOR inhibitor therapy[J]. J Clin Oncol,2009,27(16):2697-2704. 被引量:1
  • 5Jaini S,Dadachova E. FDG for therapy of metabolicallyactive tumors[J]. Semin Nucl Med,2012,42(3) : 185-189. 被引量:1
  • 6Dang CV. MYC? microRNAs and glutamine addiction incancers[J]. Cell Cycle,2009,8(20) :3243-3245. 被引量:1
  • 7Lawrence B,Gustafsson BI,Chan A,et al. The epidemiol-ogy of gastroenteropancreatic neuroendocrine tumors[J].Endocrinol Metab Clin North Am,2011,40(1) : 1-18. 被引量:1
  • 8Meng M,Chen S, Lao T,et al. Nitrogen anabolism under-lies the importance of glutaminolysis in proliferating cells—[J], Cell Cycle,2010,9(19) :3921-3932. 被引量:1
  • 9Inoki K, Li Y, Zhu T,et al. TSC2 is phosphorylated andinhibited by Akt and suppresses mTOR signalling[J], NatCell Biol,2002,4(9) :648-657. 被引量:1
  • 10Duran RV,Oppliger W?Robitaille AM,et al. Glutaminol-ysis activates rag-mTORCl signaling[J]. Mol Cell,2012,47(3):349-358. 被引量:1

二级参考文献95

  • 1高量,游磊,朱明龙,谭文松.rCHO细胞在葡萄糖限制流加培养过程中的生长与代谢特性[J].高校化学工程学报,2006,20(1):74-78. 被引量:14
  • 2Barnabe N, Butler M. The effect of glucose and glutamine on the intracellular nucleotide pool and oxygen uptake rate of a murine hybridoma [J]. Cytotechnol, 2000, 34: 47-57. 被引量:1
  • 3Valdes R, Ibarra N, Gonzalez Met al. CB. Hep-1 hybridoma growth and antibody production using protein-free medium in a hollow fiber bioreactor [J]. Cytotechnol, 2001, 35: 145-154. 被引量:1
  • 4Comer M J, Kearns M J, Wahl J et al. Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation [J]. Cytotechnol, 1990, 3: 295-299. 被引量:1
  • 5Tokashiki M, Arsi T, Hamarnoto K et al. High density culture of hybridoma cells using a perfusion culture vessel with an external centrifuge [J]. Cytotechnol, 1990, 3: 239-244. 被引量:1
  • 6Ljunggren J, Haggstrom L. Glutamine limited fed-batch culture reduces ammonium ion production in animal cells [J]. Biotechnol Lett, 1990, 12(10): 705-710. 被引量:1
  • 7Ozturk S S, Thrift J C, Blackie J D et al. Real-time monitoring and control of glucose and lactate concentrations in a mammalian cell perfusion reactor [J]. Biotechnol Bioeng, 1997, 53(4): 372-378. 被引量:1
  • 8Blankenstein G, Spohn U, Preuschoff F et al. Multichannel flow-inject-analysis biosensor system for on-line monitoring of glucose, lactate, glutarnine, glutamate and ammonia in animal cell culture [J]. Biotechnol Appl Biochem, 1994, 20: 291-307. 被引量:1
  • 9Carl D O, Mark R R. Glutamine replenishment and ammonia removal in hybridoma cell cultures via immobilized glutamine synthetase [J]. Biochemical Engineering Journal, 2001, 9, 125-133. 被引量:1
  • 10Larson TM, Gawlitzek M, Evans H et al. Chemometric evaluation of on-line high-pressure liquid chromatography in mammalian cell cultures: analysis of amino acids and glucose [J]. Biotechnol Bioeng, 2002, 77(5): 553-563. 被引量:1

共引文献24

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部